Detection of Vancomycin Resistance among Enterococcus faecalis and Staphylococcus aureus | Zendy

Ramya Rengaraj | Zendy; Shanthi Mariappan | Zendy; Uma Sekar | Zendy; Arunagiri Kamalanadhan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Detection of Vancomycin Resistance among Enterococcus faecalis and Staphylococcus aureus

Author(s) -

Ramya Rengaraj,

Shanthi Mariappan,

Uma Sekar,

Arunagiri Kamalanadhan

Publication year - 2016

Publication title -

journal of clinical and diagnostic research

Language(s) - English

Resource type - Journals

eISSN - 2249-782X

pISSN - 0973-709X

DOI - 10.7860/jcdr/2016/17552.7201

Subject(s) - teicoplanin , vancomycin , microbiology and biotechnology , staphylococcus aureus , enterococcus faecalis , linezolid , clindamycin , methicillin resistant staphylococcus aureus , enterococcus , cefoxitin , staphylococcus , antibiotics , biology , medicine , bacteria , genetics

Vancomycin remains the drug of choice for resistant gram positive infections caused by Enterococcus spp and Methicillin resistant Staphylococcus aureus (MRSA). Increased use of vancomycin has led to frank resistance and increase in MIC (MIC creep). Vancomycin intermediate Staphylococcus aureus (VISA), Vancomycin resistant Staphylococcus aureus (VRSA) & Vancomycin resistant Enterococci (VRE) are important emerging nosocomial pathogens resulting in treatment failures.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research